• Dr Philippe Wolgen returns to business full-time as Managing Director
• Lachlan Hay to continue as Acting CEO until end of September 2025
• Focus on advancing specific product development and corporate projects

CLINUVEL today announced that Dr Philippe Wolgen has returned to the business full time in his role as Managing Director and will focus in the short-term on advancing specific product development and corporate projects. Lachlan Hay will continue in the role of Acting Chief Executive Officer until the end of September 2025. 'Time away from the day-to-day demands of running the Group has given me the opportunity to consider where management energy should be focused and how we structure the next critical phase of CLINUVEL, with much of this work to be delivered in the next three months,' Dr Wolgen said. 'Returning in good health, I have agreed with the Board that I will dedicate time to specific key objectives while the executive team provides continuity of management.'